AMG 701 Ph1/2 Non-Randomized Open-Label Expansion MM
Research payments
$3,038,505
Through program year 2020, $3,038,505 in research payments was reported against AMG 701 Ph1/2 Non-Randomized Open-Label Expansion MM, across 81 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $3,038,505 | 81 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ruben Niesvizky New York, NY Named on 9 payments
- Jonathan Kaufman Atlanta, GA Named on 9 payments
- Prashant Kapoor Rochester, MN Named on 6 payments
- Deepu Madduri New York, NY Named on 5 payments
- Suzanne Lentzsch New York, NY Named on 5 payments
- Ravi Vij Saint Louis, MO Named on 5 payments
- Jeremy Larsen Scottsdale, AZ Named on 4 payments
- Saad Usmani Charlotte, NC Named on 4 payments
- Sikander Ailawadhi Jacksonville, FL Named on 4 payments
- Douglas Sborov Salt Lake City, UT Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.